Klotho Neurosciences, Inc.
KLTO
$0.48
$0.049.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.35% | 4.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.09% | 19.28% | |||
| Operating Income | 2.09% | -19.28% | |||
| Income Before Tax | 29.26% | -83.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 29.26% | -83.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 29.26% | -83.22% | |||
| EBIT | 2.09% | -19.28% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 59.62% | -48.52% | |||
| Normalized Basic EPS | 55.92% | -36.49% | |||
| EPS Diluted | 58.54% | -48.52% | |||
| Normalized Diluted EPS | 55.92% | -36.49% | |||
| Average Basic Shares Outstanding | 75.00% | 23.36% | |||
| Average Diluted Shares Outstanding | 75.00% | 23.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||